These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38940454)

  • 21. Single-Level Minimally Invasive Transforaminal Lumbar Interbody Fusion versus Anterior Lumbar Interbody Fusion with Posterior Instrumentation at L5/S1.
    Jacob KC; Patel MR; Ribot MA; Parsons AW; Vanjani NN; Pawlowski H; Prabhu MC; Singh K
    World Neurosurg; 2022 Jan; 157():e111-e122. PubMed ID: 34610449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and Radiographic Comparison of Oblique Lateral Lumbar Interbody Fusion and Minimally Invasive Transforaminal Lumbar Interbody Fusion in Patients with L4/5 grade-1 Degenerative Spondylolisthesis.
    He D; He W; Tian W; Liu B; Liu Y; Sun Y; Xing Y; Lang Z; Wang Y; Ma T; Liu M
    Orthop Surg; 2023 Jun; 15(6):1477-1487. PubMed ID: 37154089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Influence of Presenting Physical Function on Postoperative Patient Satisfaction and Clinical Outcomes Following Minimally Invasive Lumbar Decompression.
    Jacob KC; Patel MR; Park GA; Gheewala JR; Vanjani NN; Pawlowski H; Prabhu MC; Singh K
    Clin Spine Surg; 2023 Feb; 36(1):E6-E13. PubMed ID: 35759781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-level Minimally Invasive Transforaminal Lumbar Interbody Fusion Versus Anterior Lumbar Interbody Fusion for the Surgical Treatment of Isthmic Spondylolisthesis.
    Patel MR; Jacob KC; Pawlowski H; Prabhu MC; Vanjani NN; Singh K
    J Am Acad Orthop Surg; 2022 Nov; 30(21):e1382-e1390. PubMed ID: 36264190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of Prolonged Duration of Symptoms Before MIS-TLIF in a Workers' Compensation Population.
    Hartman TJ; Nie JW; Zheng E; MacGregor KR; Oyetayo OO; Federico VP; Massel DH; Sayari AJ; Singh K
    World Neurosurg; 2023 Jul; 175():e439-e446. PubMed ID: 37024079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of preoperative Veterans RAND-12 physical composite score in patients undergoing anterior lumbar interbody fusion [Retrospective Review].
    Anwar FN; Roca AM; Loya AC; Medakkar SS; Nie JW; Hartman TJ; MacGregor KR; Oyetayo OO; Zheng E; Federico VP; Sayari AJ; Lopez GD; Singh K
    J Clin Neurosci; 2024 May; 123():36-40. PubMed ID: 38522109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimally invasive versus open transforaminal lumbar interbody fusion for grade I lumbar spondylolisthesis: 5-year follow-up from the prospective multicenter Quality Outcomes Database registry.
    Chan AK; Bydon M; Bisson EF; Glassman SD; Foley KT; Shaffrey CI; Potts EA; Shaffrey ME; Coric D; Knightly JJ; Park P; Wang MY; Fu KM; Slotkin JR; Asher AL; Virk MS; Michalopoulos GD; Guan J; Haid RW; Agarwal N; Park C; Chou D; Mummaneni PV
    Neurosurg Focus; 2023 Jan; 54(1):E2. PubMed ID: 36587409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Obesity Severity on Achieving a Minimum Clinically Important Difference Following Minimally Invasive Transforaminal Lumbar Interbody Fusion.
    Cha EDK; Lynch CP; Mohan S; Geoghegan CE; Jadczak CN; Singh K
    Clin Spine Surg; 2022 Feb; 35(1):E267-E273. PubMed ID: 34050042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What Preoperative Factors Are Associated With Achieving a Clinically Meaningful Improvement and Satisfaction After Single-Level Transforaminal Lumbar Interbody Fusion for Degenerative Spondylolisthesis?
    Moorthy V; Goh GS; Cheong Soh RC
    Global Spine J; 2024 May; 14(4):1287-1295. PubMed ID: 36366979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revisions for screw malposition and clinical outcomes after robot-guided lumbar fusion for spondylolisthesis.
    Schröder ML; Staartjes VE
    Neurosurg Focus; 2017 May; 42(5):E12. PubMed ID: 28463610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of minimum clinically important difference in assessing pain, disability, and health state after transforaminal lumbar interbody fusion for degenerative lumbar spondylolisthesis.
    Parker SL; Adogwa O; Paul AR; Anderson WN; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 May; 14(5):598-604. PubMed ID: 21332281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel lumbar total joint replacement may be an improvement over fusion for degenerative lumbar conditions: a comparative analysis of patient-reported outcomes at one year.
    Alex Sielatycki J; Devin CJ; Pennings J; Koscielski M; Metcalf T; Archer KR; Dunn R; Craig Humphreys S; Hodges S
    Spine J; 2021 May; 21(5):829-840. PubMed ID: 33346156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of local steroid application in a minimally invasive transforaminal lumbar interbody fusion: results of a prospective, randomized, single-blind trial.
    Haws BE; Khechen B; Patel DV; Bawa MS; Ahn J; Bohl DD; Mayo BC; Massel DH; Guntin JA; Cardinal KL; Singh K
    J Neurosurg Spine; 2018 Nov; 30(2):222-227. PubMed ID: 30497132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-Level Anterior Lumbar Interbody Fusion versus Minimally Invasive Transforaminal Lumbar Interbody Fusion at L5/S1 for an Obese Population.
    Patel MR; Jacob KC; Zamanian C; Pawlowski H; Prabhu MC; Vanjani NN; Singh K
    Asian Spine J; 2023 Apr; 17(2):293-303. PubMed ID: 35989506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perioperative Predictors in Patients Undergoing Lateral Lumbar Interbody Fusion for Minimum Clinically Important Difference Achievement.
    Nie JW; Hartman TJ; Oyetayo OO; MacGregor KR; Zheng E; Federico VP; Massel DH; Sayari AJ; Singh K
    World Neurosurg; 2023 Jul; 175():e914-e924. PubMed ID: 37080454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous Endoscopic Robot-Assisted Transforaminal Lumbar Interbody Fusion (PE RA-TLIF) for Lumbar Spondylolisthesis: A Technical Note and Two Years Clinical Results.
    Chang M; Wang L; Yuan S; Tian Y; Zhao Y; Liu X
    Pain Physician; 2022 Jan; 25(1):E73-E86. PubMed ID: 35051154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimally Invasive Lumbar Decompression Versus Minimally Invasive Transforaminal Lumbar Interbody Fusion for Treatment of Low-Grade Lumbar Degenerative Spondylolisthesis.
    Bovonratwet P; Samuel AM; Mok JK; Vaishnav AS; Morse KW; Song J; Steinhaus ME; Jordan YJ; Gang CH; Qureshi SA
    Spine (Phila Pa 1976); 2022 Nov; 47(21):1505-1514. PubMed ID: 35867599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depressed patients with greater symptom duration before MIS-TLIF do not report inferior outcomes.
    Hartman TJ; Nie JW; Zheng E; MacGregor KR; Oyetayo OO; Federico VP; Massel DH; Sayari AJ; Singh K
    Acta Neurochir (Wien); 2023 Jul; 165(7):1923-1929. PubMed ID: 37119321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient-reported and radiographic outcomes of minimally invasive transforaminal lumbar interbody fusion for degenerative spondylolisthesis with or without reduction: A comparative study.
    Fan G; Zhang H; Guan X; Gu G; Wu X; Hu A; Gu X; He S
    J Clin Neurosci; 2016 Nov; 33():111-118. PubMed ID: 27443498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative motor weakness and the impact on patient reported outcomes in lateral lumbar interbody fusion.
    Kaul A; Roca AM; Anwar FN; Wolf JC; Khosla I; Loya AC; Medakkar SS; Federico VP; Sayari AJ; Lopez GD; Singh K
    J Clin Neurosci; 2024 Jul; 125():7-11. PubMed ID: 38733901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.